Article
CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
29 Apr 2019
Abstract excerpt
BACKGROUND: Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. Despite years of research, the accurate screening strategy is still not available in this disease and it is usually diagnosed only after the clinical signs are present. The recent technological advances in analytical methodologies enabled detection of multiple molecules in one, small sample of biological materials....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
